These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33082620)

  • 1. Insights into the Immunopathophysiology of Severe COVID-19 in Metabolic Disorders.
    Shekhar S; Copacino CE; Barrera FJ; Hall JE; Hannah-Shmouni F
    Ann Natl Acad Med Sci; 2020 Apr; 56(2):112-115. PubMed ID: 33082620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
    El-Missiry MA; El-Missiry ZMA; Othman AI
    Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, Diabetes Mellitus, and Metabolic Syndrome: Review in the Era of COVID-19.
    Abiri B; Ahmadi AR; Hejazi M; Amini S
    Clin Nutr Res; 2022 Oct; 11(4):331-346. PubMed ID: 36381471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19.
    Khwatenge CN; Pate M; Miller LC; Sang Y
    Front Immunol; 2021; 12():732913. PubMed ID: 34737743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature.
    Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS
    Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The endocrine and metabolic link between COVID-19, diabetes and obesity].
    Weis N; Thorsteinsson K; Martinussen C; Madsbad S
    Ugeskr Laeger; 2020 Jul; 182(29):. PubMed ID: 32734864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the Immune Response in Patients with Insulin Resistance, Obesity, and Diabetes to COVID-19 Vaccination.
    Warpechowski J; Leszczyńska P; Juchnicka D; Olichwier A; Szczerbiński Ł; Krętowski AJ
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and COVID-19: What are the Consequences?
    Steenblock C; Hassanein M; Khan EG; Yaman M; Kamel M; Barbir M; Lorke DE; Everett D; Bejtullah S; Lohmann T; Lindner U; Tahirukaj E; Jirjees FJ; Soliman SSM; Quitter F; Bornstein SR
    Horm Metab Res; 2022 Aug; 54(8):496-502. PubMed ID: 35724688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine Conditions and COVID-19.
    Shekhar S; Wurth R; Kamilaris CDC; Eisenhofer G; Barrera FJ; Hajdenberg M; Tonleu J; Hall JE; Schiffrin EL; Porter F; Stratakis CA; Hannah-Shmouni F
    Horm Metab Res; 2020 Jul; 52(7):471-484. PubMed ID: 32512611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients.
    Barrera FJ; Shekhar S; Wurth R; Moreno-Pena PJ; Ponce OJ; Hajdenberg M; Alvarez-Villalobos NA; Hall JE; Schiffrin EL; Eisenhofer G; Porter F; Brito JP; Bornstein SR; Stratakis CA; González-González JG; Rodíguez-Gutiérrez R; Hannah-Shmouni F
    J Endocr Soc; 2020 Sep; 4(9):bvaa102. PubMed ID: 32885126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota in a population highly affected by obesity and type 2 diabetes and susceptibility to COVID-19.
    García-Mena J; Corona-Cervantes K; Cuervo-Zanatta D; Benitez-Guerrero T; Vélez-Ixta JM; Zavala-Torres NG; Villalobos-Flores LE; Hernández-Quiroz F; Perez-Cruz C; Murugesan S; Bastida-González FG; Zárate-Segura PB
    World J Gastroenterol; 2021 Nov; 27(41):7065-7079. PubMed ID: 34887628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.
    Stefan N; Birkenfeld AL; Schulze MB
    Nat Rev Endocrinol; 2021 Mar; 17(3):135-149. PubMed ID: 33479538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia.
    Makhoul E; Aklinski JL; Miller J; Leonard C; Backer S; Kahar P; Parmar MS; Khanna D
    Cureus; 2022 Jul; 14(7):e27438. PubMed ID: 36051728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity.
    Buscemi S; Corleo D; Randazzo C
    Adv Exp Med Biol; 2021; 1353():115-129. PubMed ID: 35137371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serum levels of apelin and nitric oxide in hospitalized patients with COVID-19: association with hypertension, diabetes, obesity, and severity of disease.
    Rostamzadeh F; Najafipour H; Yazdani R; Nakhaei S; Alinaghi Langari A
    Eur J Med Res; 2022 Nov; 27(1):243. PubMed ID: 36352477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africa.
    Brennan AT; Vetter B; Masuku SD; Mtshazo B; Mashabane N; Sokhela S; Venter WD; Kao K; Meyer-Rath G
    BMC Public Health; 2023 Nov; 23(1):2291. PubMed ID: 37986070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination.
    Ali H; Alterki A; Sindhu S; Alahmad B; Hammad M; Al-Sabah S; Alghounaim M; Jamal MH; Aldei A; Mairza MJ; Husain M; Deverajan S; Ahmad R; Cherian P; Alkhairi I; Alkandari A; Abubaker J; Abu-Farha M; Al-Mulla F
    Front Immunol; 2021; 12():752233. PubMed ID: 34899701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity in people with diabetes in COVID-19 times: Important considerations and precautions to be taken.
    Alberti A; Schuelter-Trevisol F; Iser BPM; Traebert E; Freiberger V; Ventura L; Rezin GT; da Silva BB; Meneghetti Dallacosta F; Grigollo L; Dias P; Fin G; De Jesus JA; Pertille F; Rossoni C; Hur Soares B; Nodari Júnior RJ; Comim CM
    World J Clin Cases; 2021 Jul; 9(20):5358-5371. PubMed ID: 34307590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and COVID-19: Short- and Long-Term Consequences.
    Steenblock C; Hassanein M; Khan EG; Yaman M; Kamel M; Barbir M; Lorke DE; Rock JA; Everett D; Bejtullah S; Heimerer A; Tahirukaj E; Beqiri P; Bornstein SR
    Horm Metab Res; 2022 Aug; 54(8):503-509. PubMed ID: 35724689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the immune profiles of hypertensive patients with and without obesity on COVID-19 severity.
    Moll-Bernardes R; Ferreira JR; Sousa AS; Tortelly MB; Pimentel AL; Figueiredo ACBS; Schaustz EB; Secco JCP; Sales ARK; Terzi FVO; Xavier de Brito A; Sarmento RO; Noya-Rabelo MM; Fortier S; Matos E Silva FA; Vera N; Conde L; Cabral-Castro MJ; Albuquerque DC; Rosado de-Castro P; Camargo GC; Pinheiro MVT; Souza OF; Bozza FA; Luiz RR; Medei E
    Int J Obes (Lond); 2024 Feb; 48(2):254-262. PubMed ID: 37932408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.